Short-term Suicide Risk After Psychiatric Hospital Discharge.

Olfson M, Wall M, Wang S, Crystal S, Liu S-M, Gerhard T, et al. Short-term Suicide Risk After Psychiatric Hospital Discharge. Jama Psychiatry. 2016;73(11):1119-1126. DOI: 10.1001/jamapsychiatry.2016.2035. PubMed PMID: 27654151.

Long-term Risk of Dementia in Persons With Schizophrenia: A Danish Population-Based Cohort Study.

Ribe AR, Laursen TM, Charles M, Katon W, Fenger-Grøn M, Davydow D, et al.. Long-term Risk of Dementia in Persons With Schizophrenia: A Danish Population-Based Cohort Study. Jama Psychiatry. 2015;72(11):1095-101. DOI: 10.1001/jamapsychiatry.2015.1546. PubMed PMID: 26444987.

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.

Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, et al. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Jama Psychiatry. 2016;73(3):199-210. DOI: 10.1001/jamapsychiatry.2015.2955. PubMed PMID: 26842482.

Biological insights from 108 schizophrenia-associated genetic loci.

Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7. DOI: 10.1038/nature13595. PubMed PMID: 25056061; PubMed Central PMCID: PMC4112379.

Schizophrenia risk from complex variation of complement component 4.

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177-83. DOI: 10.1038/nature16549. PubMed PMID: 26814963; PubMed Central PMCID: PMC4752392.

Clinical interventions for women with schizophrenia: pregnancy.

Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand. 2013;127(1):12-22. DOI: 10.1111/j.1600-0447.2012.01897.x. PubMed PMID: 22715925.

Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.

Singh V, Singh SP, Chan K. Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. Int J Neuropsychopharmacol. 2010;13(2):257-71. DOI: 10.1017/S1461145709990654. PubMed PMID: 19775502.

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.

Stevenson JM, Reilly JL, Harris MSH, Patel SR, Weiden PJ, Prasad KM, et al. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. Transl Psychiatry. 2016;6:e739. DOI: 10.1038/tp.2016.10. PubMed PMID: 26905411; PubMed Central PMCID: PMC4872428.

A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia.

Stubbs B, De Hert M, Sepehry AA, Correll CU, Mitchell AJ, Soundy A, et al. A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatr Scand. 2014;130(6):470-86. DOI: 10.1111/acps.12313. PubMed PMID: 25041606.

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ, Okasha A, Singh B, et al. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res. 2008;100(1-3):20-38. DOI: 10.1016/j.schres.2007.11.033. PubMed PMID: 18243663.